 Home > Active Ingredient News > Drugs Articles > Merck reached a cooperation agreement with Sinopharm Group on the new crown oral drug "Monoravir"

Merck reached a cooperation agreement with Sinopharm Group on the new crown oral drug "Monoravir"

 Last Update: 2022-09-30
 Source: Internet
 Author: User

Tags

concord health supply

european markets

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 28, Merck/Sinopharm jointly announced the signing of a cooperation framework agreement whereby Merck granted Sinopharm the distribution rights and exclusive import rights of molnupiravir, an oral anti-coronavirus drug developed in collaboration with Ridgeback, and the two sides will assess the feasibility of technology transfer for the production, supply and commercialization of
the drug in China.

Monoravir is an oral small molecule new crown virus treatment drug
.

According to the terms of the cooperation framework agreement, after the approval of monolavir in China, Merck will grant the distribution and exclusive import rights of the drug in China to Sinopharm Group; Sinopharm China Biologics will actively promote localized production and supply after obtaining the technology transfer of Merck Monoravir to continue to contribute
to the fight against the new crown epidemic.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.